Developing Screening Clinical Breast Examination Implementation Strategies in Nigeria

The goal of this observational study is to engage with multilevel stakeholders to collaboratively and to systematically develop a suite of strategies for implementing breast cancer screening using clinical breast examination (CBE) in the primary health centers of Abuja, Nigeria.

The main questions it aims to answer are: What barriers and facilitators exist to conducting screening CBE in Abuja's primary care setting and what implementation strategies would support CBE in primary care clinics?

Participants will:

* Allow observation of study clinic workflows * Participate in interviews and focus group discussions regarding screening CBE implementation

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Breast Cancer Detection

Sex eligibility

All sexes

Study type

Observational

Primary location

Institute of Human Virology, Nigeria

Abuja, Nigeria

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

In order to be eligible for inclusion in the focus group discussions held with screening CBE "adopters" and "implementers," an individual must meet all of the following criteria:

Be an employee or volunteer working at a participating PHC OR Be an employee or volunteer working at Nigeria's Ministry of Health OR Be an employee or volunteer working with a non-governmental organization that performs breast cancer related activities within the catchment area of a participating PHC
Be willing to commit to keeping the content of focus group discussions confidential

In order to be eligible for inclusion in the focus group discussions held with screening CBE "recipients," an individual must meet all of the following criteria:

Be female
Be between the ages of 40 and 65 years
Be living within the catchment area of a participating PHC
Be willing to commit to keeping the content of focus group discussions confidential

Treatment and study plan

Primary outcomes

Intervention Domain Characteristics

Time frame: 1 year

Characteristics of routine clinical breast examination itself that are potential barriers and facilitators to screening implementation, emerging from thematic analysis of qualitative data organized according to the Consolidated Framework for Implementation Research.
Inner Setting Domain Characteristics

Time frame: 1 year

Characteristics of the primary care clinics that are potential barriers and facilitators to screening implementation, emerging from thematic analysis of qualitative data organized according to the Consolidated Framework for Implementation Research.
Outer Setting Domain Characteristics

Time frame: 1 year

Characteristics of both the community surrounding the clinics and the district-wide health system that are potential barriers and facilitators to screening implementation, , emerging from thematic analysis of qualitative data organized according to the Consolidated Framework for Implementation Research.
Individuals Domain Characteristics

Time frame: 1 year

Characteristics of individuals involved in screening that are potential barriers and facilitators to screening implementation, emerging from thematic analysis of qualitative data organized according to the Consolidated Framework for Implementation Research.
Implementation Domain Characteristics

Time frame: 1 year

Characteristics of activities and strategies used to implement screening that are potential barriers and facilitators to screening implementation, emerging from thematic analysis of qualitative data organized according to the Consolidated Framework for Implementation Research.

Sponsors and collaborators

Lead sponsor

Yale University

Other

Collaborators

National Cancer Institute (NCI)
University of Witwatersrand, South Africa

Registry information

Official study title

Developing an Approach to Implementing Breast Cancer Screening Using Clinical Breast Exam in the Primary Health Centers of Abuja, Nigeria

Important dates

Study start: 2025
Primary completion: 2026
Study completion: 2026
First posted: Jul 23, 2025
Registry last updated: May 29, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed